Advertisement
Screener

Cibus, Inc. (CBUS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

Cibus, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

Cibus, Inc. (CBUS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-01.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2023-05-01

  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-03-31 was $0.00.
  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-12-31 was $0.00.
  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-09-30 was $0.00.
  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $344.00K, a 92.18% increase from fiscal 2020.
  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $179.00K, a 80.22% decline from fiscal 2019.
  • Cibus, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $905.00K, a 88.04% decline from fiscal 2018.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed
2023-03-31$0.00
10-Q · filed 2023-05-01
$0.00
derived: sum of 2 quarters · filed 2023-05-01
$0.00
derived: sum of 3 quarters · filed 2023-05-01
$0.00
derived: sum of 4 quarters · filed 2023-05-01
2022-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-03
$0.00
derived: sum of 2 quarters · filed 2023-03-03
$0.00
derived: sum of 3 quarters · filed 2023-03-03
$0.00
10-K/A · filed 2023-03-03
2022-09-30$0.00
10-Q · filed 2022-11-03
$0.00
derived: sum of 2 quarters · filed 2022-11-03
$0.00
10-Q · filed 2022-11-03
$0.00
derived: sum of 4 quarters · filed 2023-05-01
2022-06-30$0.00
10-Q · filed 2022-08-04
$0.00
10-Q · filed 2022-08-04
$0.00
derived: sum of 3 quarters · filed 2023-05-01
$0.00
derived: sum of 4 quarters · filed 2023-05-01
2022-03-31$0.00
10-Q · filed 2023-05-01
$0.00
derived: sum of 2 quarters · filed 2023-05-01
$0.00
derived: sum of 3 quarters · filed 2023-05-01
$13.00K
derived: sum of 4 quarters · filed 2023-05-01
2021-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-03
$0.00
derived: sum of 2 quarters · filed 2023-03-03
$13.00K
derived: sum of 3 quarters · filed 2023-03-03
$344.00K
10-K/A · filed 2023-03-03
2021-09-30$0.00
10-Q · filed 2022-11-03
$13.00K
derived: sum of 2 quarters · filed 2022-11-03
$344.00K
10-Q · filed 2022-11-03
$344.00K
derived: sum of 4 quarters · filed 2023-03-03
2021-06-30$13.00K
10-Q · filed 2022-08-04
$344.00K
10-Q · filed 2022-08-04
$344.00K
derived: sum of 3 quarters · filed 2023-03-03
$523.00K
derived: sum of 4 quarters · filed 2023-03-03
2021-03-31$331.00K
10-Q · filed 2022-05-05
$331.00K
derived: sum of 2 quarters · filed 2023-03-03
$510.00K
derived: sum of 3 quarters · filed 2023-03-03
$510.00K
derived: sum of 4 quarters · filed 2023-03-03
2020-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-03
$179.00K
derived: sum of 2 quarters · filed 2023-03-03
$179.00K
derived: sum of 3 quarters · filed 2023-03-03
$179.00K
10-K/A · filed 2023-03-03
2020-09-30$179.00K
10-Q · filed 2021-11-04
$179.00K
derived: sum of 2 quarters · filed 2021-11-04
$179.00K
10-Q · filed 2021-11-04
2020-06-30$0.00
10-Q · filed 2021-08-05
$0.00
10-Q · filed 2021-08-05
2019-12-31$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$25.00K
derived: sum of 2 quarters · filed 2022-03-03
$552.00K
derived: sum of 3 quarters · filed 2022-03-03
$905.00K
10-K · filed 2022-03-03
2019-09-30$13.00K
10-Q · filed 2020-11-05
$540.00K
derived: sum of 2 quarters · filed 2020-11-05
$893.00K
10-Q · filed 2020-11-05
$2.05M
derived: sum of 4 quarters · filed 2021-03-04
2019-06-30$527.00K
10-Q · filed 2020-08-05
$880.00K
10-Q · filed 2020-08-05
$2.03M
derived: sum of 3 quarters · filed 2021-03-04
$3.29M
derived: sum of 4 quarters · filed 2021-03-04
2019-03-31$353.00K
10-Q · filed 2020-05-07
$1.51M
derived: sum of 2 quarters · filed 2021-03-04
$2.76M
derived: sum of 3 quarters · filed 2021-03-04
$4.66M
derived: sum of 4 quarters · filed 2021-03-04
2018-12-31$1.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04
$2.41M
derived: sum of 2 quarters · filed 2021-03-04
$4.31M
derived: sum of 3 quarters · filed 2021-03-04
$7.57M
10-K · filed 2021-03-04
2018-09-30$1.26M
10-Q · filed 2019-11-07
$3.16M
derived: sum of 2 quarters · filed 2019-11-07
$6.42M
10-Q · filed 2019-11-07
$6.76M
derived: sum of 4 quarters · filed 2020-03-05
2018-06-30$1.90M
10-Q · filed 2019-08-07
$5.16M
10-Q · filed 2019-08-07
$5.51M
derived: sum of 3 quarters · filed 2020-03-05
$6.51M
derived: sum of 4 quarters · filed 2020-03-05
2018-03-31$3.26M
10-Q · filed 2019-05-08
$3.61M
derived: sum of 2 quarters · filed 2020-03-05
$4.61M
derived: sum of 3 quarters · filed 2020-03-05
$4.61M
derived: sum of 4 quarters · filed 2020-03-05
2017-12-31$347.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
$1.35M
derived: sum of 2 quarters · filed 2020-03-05
$1.35M
derived: sum of 3 quarters · filed 2020-03-05
$1.35M
10-K · filed 2020-03-05
$1.30M
10-K · filed 2018-03-14
2017-09-30$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$1.00M
derived: sum of 2 quarters · filed 2018-11-13
$1.00M
10-Q · filed 2018-11-13
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$0.00
10-Q · filed 2018-08-01
2017-03-31$0.00
10-Q · filed 2018-05-07
2016-12-31$0.00
10-K · filed 2018-03-14
2015-12-31$0.00
10-K · filed 2018-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
SenesTech, Inc. (SNES)United States$0.004B-1.14
AMERICAN VANGUARD CORP (AVD)United States$0.057B-1.47
CVR PARTNERS, LP (UAN)United States$1.325B7.39
SCOTTS MIRACLE-GRO CO (SMG)United States$2.977B55.04
MOSAIC CO (MOS)United States$7.534B-10.55
CF Industries Holdings, Inc. (CF)United States$17.923B6.65